Last reviewed · How we verify

Influenza-like symptoms — Treatment Landscape & Competitive Intelligence

Influenza-like symptoms (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Influenza-like symptoms, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Propadrine PHENYLPROPANOLAMINE Alpharma Us Pharms Indirectly Acting Sympathomimetic Amines Sodium-dependent noradrenaline transporter 2000-01-01
Sudafed pseudoephedrine Generic (multiple manufacturers) Nasal decongestant (sympathomimetic) Alpha-1A adrenergic receptor, Alpha-2A adrenergic receptor, Beta-2 adrenergic receptor 1976-01-01
Sudafed PE phenylephrine Generic (multiple manufacturers) Alpha-1 adrenergic agonist (decongestant/vasopressor) Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor 1976-01-01
Pyrilamine mepyramine Impax Labs Central Nervous System Stimulant [EPC] Histamine H1 receptor 1973-01-01
Advil ibuprofen Generic (originally Boots Group) Nonsteroidal Anti-inflammatory Drug [EPC] Sodium-coupled monocarboxylate transporter 1, Acid-sensing ion channel 1, Aldo-keto reductase family 1 member C2 1969-01-15
Acetaminophen Paracetamol Polymedica acetaminophen Transient receptor potential cation channel subfamily V member 4 1968-01-01
Drixoral DEXBROMPHENIRAMINE Merck & Co. dexbrompheniramine Histamine H1 receptor 1963-01-01
Delsym dextromethorphan Generic (originally Roche) Antitussive (non-opioid) Taste receptor type 2 member 46, Solute carrier family 22 member 1, Cytochrome P450 2D6 1958-01-01
Mucinex guaifenesin Generic (multiple manufacturers) Expectorant [EPC] Vagal gastric reflex → increased respiratory secretions 1952-01-01
Phenergan Vc W/ Codeine PHENYLEPHRINE BITARTRATE ANI Pharmaceuticals Nonsteroidal Anti-inflammatory Drug [EPC] Alpha-1B adrenergic receptor 1952-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. Generic (multiple manufacturers) · 4 drugs in Influenza-like symptoms
  2. · 3 drugs in Influenza-like symptoms
  3. Bayer · 2 drugs in Influenza-like symptoms
  4. Chattem · 1 drug in Influenza-like symptoms
  5. Endo · 1 drug in Influenza-like symptoms
  6. Generic (originally Boots Group) · 1 drug in Influenza-like symptoms
  7. Generic (originally Roche) · 1 drug in Influenza-like symptoms
  8. Hikma · 1 drug in Influenza-like symptoms
  9. Impax Labs · 1 drug in Influenza-like symptoms
  10. Merck & Co. · 1 drug in Influenza-like symptoms
  11. Polymedica · 1 drug in Influenza-like symptoms
  12. St. Petersburg Bekhterev Research Psychoneurological Institute · 1 drug in Influenza-like symptoms

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Influenza-like symptoms:

Cite this brief

Drug Landscape (2026). Influenza-like symptoms — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/influenza-like-symptoms. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing